During the past decade, The Cardinal Stefan Wyszyński Institute of Cardiology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Cardinal Stefan Wyszyński Institute of Cardiology" #1 sponsor was "Edwards Lifesciences" with 4 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "CoRepair, Inc." with 1 trials sponsored, "Micro Interventional Devices" with 1 trials sponsored and "Renal Dynamics GmbH" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Cardinal Stefan Wyszyński Institute of Cardiology" #1 collaborator was "AmeRuss Clinical Trials LLC, USA" with 1 trials as a collaborator, "Biosensors Europe SA" with 1 trials as a collaborator and "Physio-Logic Ltd. Israel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Cardinal Stefan Wyszyński Institute of Cardiology" are "Heart Failure" (2 trials), "ASD - Atrial Septum Defect" (1 trials), "Aortic Dissection" (1 trials), "Aortic Stenosis" (1 trials) and "Aortic Valve Disease" (1 trials). Many other conditions were trialed in "The Cardinal Stefan Wyszyński Institute of Cardiology" in a lesser frequency.

Most popular intervention types in "The Cardinal Stefan Wyszyński Institute of Cardiology" are "Device" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer Muscular VSD Occluder or Amplatzer Post-Infarct Muscular VSD Occluder" (1 trials), "Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer PFO Occluder, Amplatzer ASO or Amplatzer Cribriform Occluder" (1 trials), "CAVGJ" (1 trials), "Coronary Artery Bypass Grafting (CABG) surgery" (1 trials) and "Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Cardinal Stefan Wyszyński Institute of Cardiology" are 10 trials for "All" genders.

Currently, there are NaN active trials in "The Cardinal Stefan Wyszyński Institute of Cardiology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Cardinal Stefan Wyszyński Institute of Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Cardinal Stefan Wyszyński Institute of Cardiology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".